|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM370205774 |
003 |
DE-627 |
005 |
20241113231957.0 |
007 |
cr uuu---uuuuu |
008 |
240328s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20240227-01
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1599.xml
|
035 |
|
|
|a (DE-627)NLM370205774
|
035 |
|
|
|a (NLM)38531022
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Kwok, Lawrence
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Case Report
|b Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 16.07.2024
|
500 |
|
|
|a Date Revised 12.11.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Nab-paclitaxel-related cystoid macular edema is a rare ophthalmic adverse drug reaction. We present a 54-year-old woman with metastatic hormone receptor positive, HER-2 negative breast carcinoma who developed profound bilateral vision loss after the seventh cycle of nab-paclitaxel treatment. Optical coherence tomography and macula microperimetry demonstrated macular edema and decreased threshold sensitivity, respectively. Cessation of nab-paclitaxel improved structural and functional vision after 4 weeks. The introduction of topical dorzolamide 1% in one eye demonstrated further rapid resolution of edema. We demonstrate the objective and subjective visual changes and recovery of nab-paclitaxel-related cystoid macular edema. [Ophthalmic Surg Lasers Imaging Retina 2024;55:408-411.]
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Paclitaxel
|2 NLM
|
650 |
|
7 |
|a P88XT4IS4D
|2 NLM
|
650 |
|
7 |
|a 130-nm albumin-bound paclitaxel
|2 NLM
|
650 |
|
7 |
|a Albumins
|2 NLM
|
650 |
|
7 |
|a Antineoplastic Agents, Phytogenic
|2 NLM
|
700 |
1 |
|
|a Mahmood, Alina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kumar, Sanjeev
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chang, Andrew
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 55(2024), 7 vom: 26. Juli, Seite 408-411
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:55
|g year:2024
|g number:7
|g day:26
|g month:07
|g pages:408-411
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20240227-01
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 55
|j 2024
|e 7
|b 26
|c 07
|h 408-411
|